Home › Chronic Progressive Multiple Sclerosis › Arizona
Chronic Progressive Multiple Sclerosis clinical trials in Arizona
4 studies for Chronic Progressive Multiple Sclerosis are looking for participants at sites in Arizona.
Cities in Arizona
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Arizona Neuroscience Research, LLC, Phoenix
- Perseverance Research Center, LLC (PRC), Scottsdale
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 30, 2026 · NCT07299019A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Clinical Endpoints, LLC, Scottsdale
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 30, 2026 · NCT07609719A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Arizona Neuroscience Research, LLC, Pheonix
- Perseverance Research Center, Scottsdale
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Sep 22, 2026 · NCT07067463A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Ctr for Neurology and Spine, Phoenix
- AZ Integrated Neuro and Spine, Phoenix
- Center for Neurosciences, Tucson
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07225504From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.